Skip to content

Clinical Outcome Study of Immune Subtypes in Adolescent Depression

Clinical Outcome Study of Immune Subtypes in Adolescent Depression

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500104990
Enrollment
Unknown
Registered
2025-06-26
Start date
2024-04-15
Completion date
Unknown
Last updated
2025-06-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adolescents with Major Depressive Disorder

Interventions

Adolescents with MDD group:None

Sponsors

The Affiliated Brain Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to 18 Years

Inclusion criteria

Inclusion criteria: Adolescents with Major Depressive Disorder (MDD) 1. Adolescents aged 10-18 years old; 2. Meeting the diagnostic criteria for Major Depressive Disorder as per DSM-5; 3. Obtaining written informed consent from the patient and their legal guardian. Healthy Controls 1. Children and adolescents aged 10-18 years old; 2. Obtaining written informed consent from the participant and their legal guardian.

Exclusion criteria

Exclusion criteria: Adolescents with Major Depressive Disorder (MDD) 1. Diagnosis of schizophrenia, schizoaffective disorder, bipolar disorder, autism spectrum disorder, or intellectual disability based on the Chinese version of the Mini-International Neuropsychiatric Interview (MINI) assessment; 2. Presence of intellectual disability with an IQ < 80; 3. Severe visual, auditory, or language impairments; 4. History of brain injury, epilepsy, or severe physical illnesses. Healthy Controls 1. Presence of any mental disorder; 2. Subthreshold depression, subthreshold mania, or high-risk mental illness syndrome; 3. Family history of mental disorders; 4. IQ < 80 as per the Wechsler Intelligence Scale for Children, Fourth Edition (WISC-IV); 5. Severe visual, auditory, or language impairments; 6. History of brain injury, epilepsy, or severe physical illnesses.

Design outcomes

Primary

MeasureTime frame
Montgomery-Asberg Depression Rating Scale Score(MADRS);

Secondary

MeasureTime frame
Cognitive function;Columbia Suicide Severity Rating Scale Score, C-SSRS;Hamilton Anxiety Scale Score;Electroencephalogram Data;MRI Data;Childhood Trauma Questionnaire Score;Hamilton Depression Rating Scale Score-32 Items;Young Mania Rating Scale Score;Sleep rhythm;The Pittsburgh Sleep Quality Index;Ostracism Experience Scale Score for Adolescents;Children and Adolescents Peer Relationship Scale Score;

Countries

China

Contacts

Public ContactYanling Zhou

The Affiliated Brain Hospital of Guangzhou Medical University

zhouylivy@aliyun.com+86 20 8126 8113

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026